News
Margaret A. Tempero, MD, Named Editor-in-Chief of JNCCN
JNCCN - Journal of the National Comprehensive Cancer Network named Margaret A. Tempero, MD, UCSF Helen Diller Family Comprehensive Cancer Center, as the new Editor-in-Chief, succeeding Harold J. Burstein, MD, PhD, who served in the position for five years. "Dr. Tempero’s highly esteemed career and
UCSF Schools Lead the Nation in NIH Biomedical Research Funds
UC San Francisco’s four professional schools topped the nation in federal research funding in 2013, with the University as a whole ranking first among public recipients and second overall in funds from the National Institutes of Health (NIH), according to annual NIH figures. These highly competitive
Paradox of Cigarette Sales in Pharmacies Focus of New Movement
Pharmacies, focused on the health and wellbeing of their customers, have long been saddled with a paradox: they sell cigarettes and other tobacco products, even though tobacco use is the nation’s leading cause of preventable death. If retailers, particularly pharmacies, were to discontinue selling
Killing Cancer Through the Immune System (Part II)
continued from " Killing Cancer Through the Immune System," Feb 4, 2014, UCSF.edu “For the longest time, people did not believe this was possible,” said Lawrence Fong, MD, associate professor of medicine at UCSF and one of the University’s lead investigators in the expanding use of immunotherapy
Killing Cancer Through the Immune System
What if the body could heal itself of even the most aggressive and deadly tumors? In the span of a few years, the idea has gone from New Age notion to medical reality. Researchers are investigating the potential of immunotherapy to be a powerful, effective and long-lasting solution to kill cancer
Scientists Call for Screening Mammography Every Two Years for Most Women
Adoption of new guidelines recommending screening mammography every two years for women ages 50 to 74 would result in breast cancer screening that is equally effective, while saving the United States $4.3 billion a year in health care costs, according to a study led by UC San Francisco. The study
ExRNA Research May Refine Prostate Cancer Treatment
Urology faculty member Robert Blelloch, MD, PhD, is leading an NIH-funded project examining the role extracellular RNA (exRNA) might play in prostate and other cancers. Within the cell, RNA helps to guide protein production, but scientists have learned in recent years that small segments of RNA are